Treatment of Refractory Mycobacterium avium Complex Lung Disease with a Moxifloxacin-Containing Regimen

Moxifloxacin (MXF) has in vitro and in vivo activity against Mycobacterium avium complex (MAC) in experimental models. However, no data are available concerning its treatment effect in patients with MAC lung disease. The aim of this study was to evaluate the clinical efficacy of an MXF-containing re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Koh, Won-Jung, Hong, Goohyeon, Kim, Su-Young, Jeong, Byeong-Ho, Park, Hye Yun, Jeon, Kyeongman, Kwon, O Jung, Lee, Seung-Heon, Kim, Chang Ki, Shin, Sung Jae
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2013
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3632919/
https://ncbi.nlm.nih.gov/pubmed/23478956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02281-12
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados